TAVR: The Next 3 Years

What’s on the horizon for transcatheter aortic valve replacement (TAVR)? Dr. Michael Reardon, a world expert in TAVR who has led many of the clinical trials in this space, shares his insights at Piedmont Heart’s Napa Valley Cardiology Conference.